245 related articles for article (PubMed ID: 26209361)
1. SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy.
Yuan Q; Zhan L; Zhou QY; Zhang LL; Chen XM; Hu XM; Yuan XC
Eur J Pharmacol; 2015 Oct; 764():554-561. PubMed ID: 26209361
[TBL] [Abstract][Full Text] [Related]
2. Furry promotes acetylation of microtubules in the mitotic spindle by inhibition of SIRT2 tubulin deacetylase.
Nagai T; Ikeda M; Chiba S; Kanno S; Mizuno K
J Cell Sci; 2013 Oct; 126(Pt 19):4369-80. PubMed ID: 23886946
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells.
Hashimoto-Komatsu A; Hirase T; Asaka M; Node K
Hypertens Res; 2011 Aug; 34(8):949-56. PubMed ID: 21677656
[TBL] [Abstract][Full Text] [Related]
6. The tubulin deacetylase sirtuin-2 regulates neuronal differentiation through the ERK/CREB signaling pathway.
Jeong SG; Cho GW
Biochem Biophys Res Commun; 2017 Jan; 482(1):182-187. PubMed ID: 27838300
[TBL] [Abstract][Full Text] [Related]
7. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels.
Skoge RH; Dölle C; Ziegler M
DNA Repair (Amst); 2014 Nov; 23():33-8. PubMed ID: 24814981
[TBL] [Abstract][Full Text] [Related]
8. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.
Siegel D; Bersie S; Harris P; Di Francesco A; Armstrong M; Reisdorph N; Bernier M; de Cabo R; Fritz K; Ross D
Redox Biol; 2021 Feb; 39():101840. PubMed ID: 33360352
[TBL] [Abstract][Full Text] [Related]
9. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
[TBL] [Abstract][Full Text] [Related]
11. Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.
Yang D; Liu W; Ma L; Wang Y; Ma J; Jiang M; Deng X; Huang F; Yang T; Chen M
Mol Med Rep; 2017 Nov; 16(5):6634-6641. PubMed ID: 28901418
[TBL] [Abstract][Full Text] [Related]
12. Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2.
Liu Z; Zhao N; Zhu H; Zhu S; Pan S; Xu J; Zhang X; Zhang Y; Wang J
Cardiovasc Diabetol; 2015 Sep; 14():125. PubMed ID: 26394923
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
14. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
[TBL] [Abstract][Full Text] [Related]
16. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
18. High glucose concentration suppresses a SIRT2 regulated pathway that enhances neurite outgrowth in cultured adult sensory neurons.
Schartner E; Sabbir MG; Saleh A; Silva RV; Roy Chowdhury S; Smith DR; Fernyhough P
Exp Neurol; 2018 Nov; 309():134-147. PubMed ID: 30102915
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
[TBL] [Abstract][Full Text] [Related]
20. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
